[SRNE] YoY Quarter Result on 31-Dec-2011 [#Q4]

Stock
[SRNE] Sorrento Therapeutics, Inc.
Announcement Date
30-Mar-2012
Financial Year
2011
Quarter
31-Dec-2011 [#Q4]
Profit Trend
QoQ- -8.55%
YoY- -305.32%
Quarter Report
SRNE's Result
SRNE's Financial Summary
View:
Show?
Quarter Result
31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 CAGR
Revenue 798 101 122 128 512 5 0 -
PBT -10,207 -11,296 -3,236 -3,236 -1,808 -710 144 -
Tax 1 4 -3,090 -2,474 -1,620 -138 -2 -
NP -8,505 -11,296 -1,755 -762 -188 -686 -45 139.46%
Tax Rate - - - - - - 1.12% -
Total Cost 9,303 11,397 1,877 890 700 691 45 143.06%
Ratio Analysis
31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 CAGR
NP Margin -1,065.79 -11,217.68 -1,438.58 -595.84 -36.75 -12,672.10 0.00 -
Per Share
31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 CAGR
EPS -0.23 -0.49 -0.14 -0.07 -0.02 -0.08 -0.10 14.88%
EPS Diluted -0.23 -0.49 -0.14 -0.07 -0.02 -0.08 -0.10 14.88%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.